Compare Becton Dickinson and Co (BDX) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Orion Office REIT Inc — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Orion Office REIT Inc trades at $2.78 (market cap $156.87M). The key difference: Becton Dickinson and Co is far larger — about 311.9× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays the higher dividend (2.91%). Which is the better fit depends on your goals.
| BDX | ONL | |
|---|---|---|
Market Cap | $48.93B | $156.87M |
Sector | Health | Real Estate |
52-Week High | $185.39 | $3.04 |
52-Week Low | $138.62 | $1.93 |
Enterprise Value | $65.03B | $573.80M |
Dividend Yield | 2.34% | 2.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
ONL trades at $2.82, up 8.46% today, with strong technical indicators showing bullish momentum. The stock shows mixed fundamentals with a low P/B ratio of 0.25 but negative profitability metrics including -65.66% net income margin. Recent Q2 2026 earnings beat expectations with EPS of $0.42 versus -$0.07 forecast, while the company continues strategic portfolio repositioning and maintains a $0.02 dividend payment.
Outlook remains cautious due to persistent net losses and declining revenue trends, though analyst consensus is evenly split between Buy and Hold ratings. Key risks include high debt levels with 39.68% debt-to-asset ratio and ongoing negative cash flow from operations. The technical bullish signal suggests short-term upside potential despite fundamental challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
